These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15084687)

  • 1. Compatibility of budesonide inhalation suspension with four nebulizing solutions.
    McKenzie JE; Cruz-Rivera M
    Ann Pharmacother; 2004 Jun; 38(6):967-72. PubMed ID: 15084687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium.
    Bonasia PJ; McVicar WK; Bill W; Ong S
    Respir Care; 2008 Dec; 53(12):1716-22. PubMed ID: 19025708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W; Schwabe A; Krämer I
    J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol characteristics of admixture of budesonide inhalation suspension with a beta2-agonist, procaterol.
    Itazawa T; Adachi Y; Ito Y; Higuchi O; Mochizuki H; Shimojo N; Inoue T
    Allergol Int; 2013 Mar; 62(1):131-5. PubMed ID: 23348859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical compatibility of nebulizable drug admixtures containing budesonide and colistimethate or hypertonic saline.
    Klemmer A; Krämer I; Kamin W
    Int J Pharm Compd; 2013; 17(3):254-61. PubMed ID: 24046941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
    Kamin W; Schwabe A; Krämer I
    Int J Chron Obstruct Pulmon Dis; 2007; 2(4):599-607. PubMed ID: 18268934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
    Krämer I; Schwabe A; Lichtinghagen R; Kamin W
    Pharmazie; 2007 Oct; 62(10):760-6. PubMed ID: 18236781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.
    Leflein JG; Szefler SJ; Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Smith JA
    Pediatrics; 2002 May; 109(5):866-72. PubMed ID: 11986448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of nebulizer solution admixtures.
    Joseph JC
    Ann Pharmacother; 1997 Apr; 31(4):487-9. PubMed ID: 9101012
    [No Abstract]   [Full Text] [Related]  

  • 11. Compatibility and stability of labetalol hydrochloride in commonly used intravenous solutions.
    Yuen PH; Taddei CR; Wyka BE; Chaudry IA
    Am J Hosp Pharm; 1983 Jun; 40(6):1007-9. PubMed ID: 6869384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of pulmicort suspension plus salbutamol and ipratropium bromide for management of acute asthma exacerbation in children: a comparative study].
    Chen ZG; Li M; Chen H; Chen YF; Chen FH; Ji JZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):470-2. PubMed ID: 18359717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a stability-indicating high-performance liquid chromatography method for the simultaneous determination of albuterol, budesonide, and ipratropium bromide in compounded nebulizer solutions.
    Blewett AJ; Varma D; Gilles T; Butcher R; Jacob J; Amazan J; Jansen SA
    J AOAC Int; 2011; 94(1):110-7. PubMed ID: 21391487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension.
    Nikander K; Turpeinen M; Wollmer P
    J Aerosol Med; 1999; 12(2):47-53. PubMed ID: 10539706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs.
    Bonasia P; Cook C; Cheng Y; Ong S
    Curr Med Res Opin; 2007 Oct; 23(10):2477-83. PubMed ID: 17784997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of nebulized budesonide is affected by nebulizer type and breathing pattern.
    O'Callaghan C; White J; Jackson J; Barry PW; Kantar A
    J Pharm Pharmacol; 2005 Jun; 57(6):787-90. PubMed ID: 15969935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of budesonide inhalation suspension nebulization by mesh nebulizer in Japanese infants and young children with bronchial asthma in 12-week, randomised, open study].
    Tezuka J; Motomura C; Ikei J; Ide K; Kando N; Goto M; Taba N; Hayashi D; Murakami Y; Moriyasu Y; Soebijanto K; Shibata R; Okada K; Okada H; Nishima S
    Arerugi; 2008 Aug; 57(8):1034-42. PubMed ID: 18781108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.